Longeveron Inc. revenue for the last year amounted to 2.39 M USD, the most of which — 2.39 M USD — came from its highest performing source at the moment, Regenerative Medicines, the year earlier bringing 709.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought Longeveron Inc. 2.39 M USD, and the year before that — 709.00 k USD.